Advanced

Colon cancer prevalence and estimation of differing care needs of colon cancer patients

Gatta, G; Capocaccia, R; Berrino, F; Ruzza, M R; Contiero, P; Möller, Torgil LU and EUROPREVAL Working Group, and the (2004) In Annals of Oncology 15(7). p.1136-1142
Abstract
BACKGROUND: Cancer prevalence-the proportion of people in a population with a diagnosis of cancer-includes groups with widely differing cancer care needs. We estimated the proportions of the prevalent colon cancer cases requiring initial care, terminal care and follow-up. PATIENTS AND METHODS: Prevalence by year since diagnosis was estimated from incidence and vital status data on 243,471 colon cancer cases collected by EUROPREVAL from 36 European population-based cancer registries. The proportions of cured and fatal cases were estimated by applying 'cure' survival models to the dataset. The proportion of recurrence-free cases was estimated by analysis of a representative sample of 278 colon cancer patients from the Lombardy Cancer... (More)
BACKGROUND: Cancer prevalence-the proportion of people in a population with a diagnosis of cancer-includes groups with widely differing cancer care needs. We estimated the proportions of the prevalent colon cancer cases requiring initial care, terminal care and follow-up. PATIENTS AND METHODS: Prevalence by year since diagnosis was estimated from incidence and vital status data on 243,471 colon cancer cases collected by EUROPREVAL from 36 European population-based cancer registries. The proportions of cured and fatal cases were estimated by applying 'cure' survival models to the dataset. The proportion of recurrence-free cases was estimated by analysis of a representative sample of 278 colon cancer patients from the Lombardy Cancer Registry (LCR), northern Italy. RESULTS: The proportions of total prevalence requiring initial care was estimated at 12% in the LCR and 10% in Italy and Europe. Recurrence-free patients formed 89% of the total prevalence in the LCR and 91% in Italy and Europe. Eleven per cent (LCR) and 9% (Italy, Europe) of the total prevalence had recurred and consisted of patients in the terminal phase of their illness. CONCLUSIONS: In 1992, 660,000 people were living with a diagnosis of colon cancer in Europe. We have estimated the proportions of this prevalence requiring particular types health care in the years following diagnosis, providing data useful for planning the allocation of health-care resources. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
care prevalence, population-based cancer registries, Europe, colon cancer
in
Annals of Oncology
volume
15
issue
7
pages
1136 - 1142
publisher
Oxford University Press
external identifiers
  • pmid:15205210
  • scopus:4143053409
ISSN
1569-8041
DOI
10.1093/annonc/mdh234
language
English
LU publication?
yes
id
e5da8b80-83e3-4f31-86b0-3b4c1d945f6f (old id 1129058)
date added to LUP
2008-08-15 15:34:21
date last changed
2017-01-01 07:08:33
@article{e5da8b80-83e3-4f31-86b0-3b4c1d945f6f,
  abstract     = {BACKGROUND: Cancer prevalence-the proportion of people in a population with a diagnosis of cancer-includes groups with widely differing cancer care needs. We estimated the proportions of the prevalent colon cancer cases requiring initial care, terminal care and follow-up. PATIENTS AND METHODS: Prevalence by year since diagnosis was estimated from incidence and vital status data on 243,471 colon cancer cases collected by EUROPREVAL from 36 European population-based cancer registries. The proportions of cured and fatal cases were estimated by applying 'cure' survival models to the dataset. The proportion of recurrence-free cases was estimated by analysis of a representative sample of 278 colon cancer patients from the Lombardy Cancer Registry (LCR), northern Italy. RESULTS: The proportions of total prevalence requiring initial care was estimated at 12% in the LCR and 10% in Italy and Europe. Recurrence-free patients formed 89% of the total prevalence in the LCR and 91% in Italy and Europe. Eleven per cent (LCR) and 9% (Italy, Europe) of the total prevalence had recurred and consisted of patients in the terminal phase of their illness. CONCLUSIONS: In 1992, 660,000 people were living with a diagnosis of colon cancer in Europe. We have estimated the proportions of this prevalence requiring particular types health care in the years following diagnosis, providing data useful for planning the allocation of health-care resources.},
  author       = {Gatta, G and Capocaccia, R and Berrino, F and Ruzza, M R and Contiero, P and Möller, Torgil and EUROPREVAL Working Group, and the},
  issn         = {1569-8041},
  keyword      = {care prevalence,population-based cancer registries,Europe,colon cancer},
  language     = {eng},
  number       = {7},
  pages        = {1136--1142},
  publisher    = {Oxford University Press},
  series       = {Annals of Oncology},
  title        = {Colon cancer prevalence and estimation of differing care needs of colon cancer patients},
  url          = {http://dx.doi.org/10.1093/annonc/mdh234},
  volume       = {15},
  year         = {2004},
}